Abstract:Background Public resources of chemical compound are in a rapid growth both in quantity and the types of data-representation. To comprehensively understand the relationship between the intrinsic features of chemical compounds and protein targets is an essential task to evaluate potential protein-binding function for virtual drug screening. In previous studies, correlations were proposed between bioactivity profiles and target networks, especially when chemical structures were similar. With the lack of effective quantitative methods to uncover such correlation, it is demanding and necessary for us to integrate the information from multiple data sources to produce an comprehensive assessment of the similarity between small molecules, as well as quantitatively uncover the relationship between compounds and their targets by such integrated schema. Results In this study a multi-view based clustering algorithm was introduced to quantitatively integrate compound similarity from both bioactivity profiles and structural fingerprints. Firstly, a hierarchy clustering was performed with the fused similarity on 37 compounds curated from PubChem. Compared to clustering in a single view, the overall common target number within fused classes has been improved by using the integrated similarity, which indicated that the present multi-view based clustering is more efficient by successfully identifying clusters with its members sharing more number of common targets. Analysis in certain classes reveals that mutual complement of the two views for compound description helps to discover missing similar compound when only single view was applied. Then, a large-scale drug virtual screen was performed on 1267 compounds curated from Connectivity Map (CMap) dataset based on the fused similarity, which obtained a better ranking result compared to that of single-view. These comprehensive tests indicated that by combining different data representations; an improved assessment of target-specific compound similarity can be achieved. Conclusions Our study presented an efficient, extendable and quantitative computational model for integration of different compound representations, and expected to provide new clues to improve the virtual drug screening from various pharmacological properties. Scripts, supplementary materials and data used in this study are publicly available at http://lifecenter.sgst.cn/fusion/ .

In-silico Target Prediction by Ensemble Chemogenomic Model Based on Multi-Scale Information of Chemical Structures and Protein Sequences.

TargetHunter: an in Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Incorporating Chemical Sub-Structures and Protein Evolutionary Information for Inferring Drug-Target Interactions

A Systematic Prediction Of Multiple Drug-Target Interactions From Chemical, Genomic, And Pharmacological Data

Improved Prediction Of Drug-Target Interactions Based On Ensemble Learning With Fuzzy Local Ternary Pattern

Current Advances in Ligand‐based Target Prediction

Prediction of Chemical-Protein Interactions: Multitarget-Qsar Versus Computational Chemogenomic Methods

Large-scale Prediction of Drug–target Interactions Using Protein Sequences and Drug Topological Structures

Predicting Drug-Target Interaction for New Drugs Using Enhanced Similarity Measures and Super-Target Clustering.

Theoretical Approaches to the Prediction of the Biological Targets of Small-Molecular Compounds Based on Chemogenomic Information

Synergizing Chemical Structures and Bioassay Descriptions for Enhanced Molecular Property Prediction in Drug Discovery

Prediction of compound-target interaction using several artificial intelligence algorithms and comparison with a consensus-based strategy

Quantitatively integrating molecular structure and bioactivity profile evidence into drug-target relationship analysis

Global Optimization-Based Inference of Chemogenomic Features from Drug-Target Interactions

Identification of potential drug-targets by combining evolutionary information extracted from frequency profiles and molecular topological structures

Computational Screening for Active Compounds Targeting Protein Sequences: Methodology and Experimental Validation

In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences

Prediction of Potential Drug Targets Based on Simple Sequence Properties

Genome-Scale Screening Of Drug-Target Associations Relevant To K-I Using A Chemogenomics Approach

In silico prediction of chemical mechanism-of-action via an improved network-based inference method.